Alvotech   Report issue

For profit Phase 1 Phase 3
Founded: Reykjavik Iceland (2013)
Status: No NME R&D (2013)

Organization Overview

First Clinical Trial
2018
NCT03579823
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Alvotech Swiss AG